Trial Profile
Good combination therapy with alpha-blocker plus imidafenacin or mirabegron for nocturia in overactive bladder with benign prostatic hyperplasia; prospective randomized trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Mar 2013
Price :
$35
*
At a glance
- Drugs Imidafenacin (Primary) ; Mirabegron (Primary) ; Alpha adrenergic receptor antagonists
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- Acronyms Good-Night 2
- 30 Mar 2013 New trial record